Improvement in sodium cromoglycate delivery from a spacer device by use of an antistatic lining, immediate inhalation, and avoiding multiple actuations of drug.

C O'Callaghan, J Lynch, M Cant, C Robertson

Department of Thoracic Medicine, Royal Children's Hospital, Parkville, Melbourne, Australia.

BACKGROUND--Aerosols generated from metered dose inhalers may be highly charged. The aim of this study was to determine whether lining the walls of a polycarbonate spacer device with an antistatic agent would result in an increase in drug output. The effects of multiple actuations of drug into the spacer device and increasing residence time of drug within the spacer were also determined. METHODS--The amount of sodium cromoglycate contained in particles of various size available for inhalation (per 5 mg actuation) from a 750 ml polycarbonate spacer was determined by impinger measurement and spectrophotometric assay. RESULTS--Lining the spacer with an antistatic agent increased the mean (SD) amount of sodium cromoglycate in particles < 5 microns available for inhalation (per 5 mg actuation) by 244% from (0.59 (0.03) to 1.44 (0.2) mg). When there was a 20 second interval between actuation into the spacer device and inhalation, sodium cromoglycate available for inhalation in particles < 5 micrograms decreased by 67% (from 0.59 (0.03) mg to 0.2 (0.01) mg). Use of the spacer device increased sodium cromoglycate available for inhalation in respirable particles (< 5 microns) by 18% compared with direct delivery by metered dose inhaler. Multiple actuations into the spacer decreased the amount of sodium cromoglycate available for inhalation in particles < 5 microns by 31% after two actuations and 56% after three acutations. CONCLUSIONS--Multiple actuations of sodium cromoglycate into a spacer device before inhalation should be avoided, and inhalation from spacer devices should take place immediately after actuation to ensure maximum dose. Lining of a standard spacer device with an antistatic agent significantly increased output of sodium cromoglycate. This may have implications for improved therapeutic response and drug cost.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Improvement in sodium cromoglycate delivery from a spacer device.

M L Everard
Thorax 1994 49: 289. [PDF]

This article has been cited by other articles:

• Brock, T. P., Williams, D. M. (2001). Clinical Considerations in the Use of Inhalation Delivery Devices. Journal of Pharmacy Practice 14: 277-295 [Abstract]  
• Dompeling, E, Oudesluys-Murphy, A M, Janssens, H M, Hop, W, Brinkman, J G, Sukhai, R N, de Jongste, J C (2001). Randomised controlled study of clinical efficacy of spacer therapy in asthma with regard to electrostatic charge. Arch. Dis. Child. 84: 178-182 [Abstract] [Full Text]  
• O'Callaghan, C., Barry, P. W (2000). Asthma drug delivery devices for children. BMJ 320: 664-664 [Full Text]  
• (1999). Inhalation devices and propellants. CMAJ 161: s44-50 [Full Text]  
• Cole, C. H., Colton, T., Shah, B. L., Abbasi, S., MacKinnon, B. L., Demissie, S., Frantz, I. D. (1999). Early Inhaled Glucocorticoid Therapy to Prevent Bronchopulmonary Dysplasia. NEJM 340: 1005-1010 [Abstract] [Full Text]  
• O'Callaghan, C., Barry, P. (1997). Spacer devices in the treatment of asthma. BMJ 314: 1061-1061 [Full Text]